Two new members i Oslo Cancer Cluster: NorGeno Tech & DNVGL
NorGeno Tech & DNVGL are now members of the Oslo Cancer Cluster. Please find more information on the new members below.
About NorGeno Tech
NorGenoTech AS s a start-up company arose from the success of the EU FP6 project ‘COMICS’ in making improved high throughput methods for analysis of DNA damage and repair with the comet assay. Our main business is innovative products development, genotoxicity testing, expertise and consultancy.
We aim at becoming a leading comet technology player in Europe, carrying out laboratory services and providing modern equipment for high throughput diagnostic use and screening of chemicals, nutrients and drugs.
The founders of the company Gunnar Brunborg, Andrew Collins and Sergey Shaposhnikov are leading researchers in the field responsible for numerous innovations. Chris Brøvig is a business generalist involved in commercialisation of our inventions
ACTIVITIES WITHIN THE ONCOLOGY FIELD:
1. Genotoxicity testing of novel chemicals and drugs
2. Developing diagnostic tools for measuring DNA integrity in patients at the level of individual cells.
For more information see here.
About DNVGL
Driven by its purpose of safeguarding life, property and the environment, DNV GL enables organizations to advance the safety and sustainability of their business. We help businesses assure the performance of their organizations, products, people, facilities and supply chains through certification, accreditation, verification, assessment, and training services. Partnering with our customers, we build sustainable business performance and create stakeholder trust across all types of industries. Operating in more than 100 countries, our 14,000 professionals are dedicated to helping our customers make the world safer, smarter and greener.
We support healthcare organizations across the globe to apply a systems thinking to address risks and deliver high-quality, person centered care. Through our research programmes we are working to identify transformational changes needed in order to make healthcare safer and more sustainable. As a trusted partner, we work with healthcare providers, national and regional health authorities and key stakeholders around the world to improve healthcare quality and facilitate the provision of patient-centered, safe care. Building on more than 150 years of expertise in working with high risk industries to make them safer.
Building on our strong presence and recognition in Food & Beverage and Healthcare, we are expanding our scope and service offerings as a global assurance provider in the Life Sciences domain. More specifically to help organizations preserve health and provide food – two of the most fundamental human needs.
The world population is growing and life expectancy is increasing. Combined, this will put significant pressure on our food supply and healthcare systems. One response to this is the rapid advancement in supporting technologies and the harnessing of big data. But there are challenges related to quality, safety and integrity that must to be addressed. The involvement of independent assurance providers will be increasingly important.
